Adelphi Research
Pam Hallworth has extensive experience in the research and healthcare industry. Pam started their career at Adelphi Research Global in 2012 as a Senior Research Executive and worked in that role until 2015. Pam then joined Adelphi Real World as an Associate Manager in the Oncology department, later being promoted to a Project Manager. From 2018 onwards, Pam returned to Adelphi Research Global and worked as an Associate Director before becoming a Research Director. Pam specializes in disease-specific programs in the Oncology field, including Prostate cancer, Head & Neck cancers, Advanced melanoma, Chronic lymphocytic leukaemia, Follicular Lymphoma, and Diffuse large B-cell lymphoma.
Pam Hallworth obtained a Bachelor of Science (BSc) degree in Biology and Psychology from Keele University, where they studied from 2007 to 2010. Additionally, they hold certifications in Certified Agile Leadership Essentials (CAL-E) and Certified Agile Leadership for Orgs (CAL-O) from Scrum Alliance, which they obtained in March 2023. Pam also has an Advanced Certificate in Market & Social Research Practice, awarded by the Market Research Society (MRS), although the details of the certification's acquisition are not provided.
This person is not in any offices
Adelphi Research
Adelphi Research is a global healthcare market insight consultancy that navigates brand challenges, informs decisions and inspires stakeholders to take action. Established for over 30 years, we help pharma and healthcare companies to answer the complex business questions that underpin brand success. At Adelphi Research, time never stands still. We continue to innovate, evolve and grow. With headquarters near Manchester, UK and Doylestown, PA, USA, we have a diverse team of over 100 in-house consultants, research professionals, advanced analytics specialists and operational experts. Adelphi Research is part of Adelphi Group, an Omnicom Group Inc. company. We offer a unique, multi-perspective approach through leveraging the knowledge and talent in our sister companies which include medical communications, real world evidence, values and outcomes businesses.